These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2153398

  • 1. The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
    Hospers GA, de Vries EG, Mulder NH.
    Br J Cancer; 1990 Jan; 61(1):79-82. PubMed ID: 2153398
    [Abstract] [Full Text] [Related]

  • 2. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG.
    Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486
    [Abstract] [Full Text] [Related]

  • 3. A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.
    Hospers GA, Meijer C, de Leij L, Uges DR, Mulder NH, de Vries EG.
    Int J Cancer; 1990 Jul 15; 46(1):138-44. PubMed ID: 2163989
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.
    Hospers GA, Mulder NH, de Jong B, de Ley L, Uges DR, Fichtinger-Schepman AM, Scheper RJ, de Vries EG.
    Cancer Res; 1988 Dec 01; 48(23):6803-7. PubMed ID: 2846161
    [Abstract] [Full Text] [Related]

  • 5. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.
    Plooy AC, Fichtinger-Schepman AM, Schutte HH, van Dijk M, Lohman PH.
    Carcinogenesis; 1985 Apr 01; 6(4):561-6. PubMed ID: 4039227
    [Abstract] [Full Text] [Related]

  • 6. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
    Groen HJ, Sleijfer S, Meijer C, Kampinga HH, Konings AW, De Vries EG, Mulder NH.
    Br J Cancer; 1995 Dec 01; 72(6):1406-11. PubMed ID: 8519652
    [Abstract] [Full Text] [Related]

  • 7. Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line.
    Timmer-Bosscha H, Hospers GA, Meijer C, Mulder NH, Muskiet FA, Martini IA, Uges DR, de Vries EG.
    J Natl Cancer Inst; 1989 Jul 19; 81(14):1069-75. PubMed ID: 2544740
    [Abstract] [Full Text] [Related]

  • 8. Effect of novobiocin on cisplatin cytotoxicity and DNA interstrand cross-link formation in a cisplatin-resistant, small-cell lung carcinoma cell line.
    de Jong S, Timmer-Bosscha H, de Vries EG, Mulder NH.
    Int J Cancer; 1993 Jan 02; 53(1):110-7. PubMed ID: 8380054
    [Abstract] [Full Text] [Related]

  • 9. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
    Fokkema E, Groen HJ, Helder MN, de Vries EG, Meijer C.
    Biochem Pharmacol; 2002 Jun 01; 63(11):1989-96. PubMed ID: 12093475
    [Abstract] [Full Text] [Related]

  • 10. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, de Vries EG.
    Cancer Res; 1992 Dec 15; 52(24):6885-9. PubMed ID: 1458477
    [Abstract] [Full Text] [Related]

  • 11. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.
    Peters GJ, Van Moorsel CJ, Lakerveld B, Smid K, Noordhuis P, Comijn EC, Weaver D, Willey JC, Voorn D, Van der Vijgh WJ, Pinedo HM.
    Int J Oncol; 2006 Jan 15; 28(1):237-44. PubMed ID: 16328001
    [Abstract] [Full Text] [Related]

  • 12. Ultrastructural morphology and localisation of cisplatin-induced platinum-DNA adducts in a cisplatin-sensitive and -resistant human small cell lung cancer cell line using electron microscopy.
    Meijera C, van Luyn MJ, Nienhuis EF, Blom N, Mulder NH, de Vries EG.
    Biochem Pharmacol; 2001 Mar 01; 61(5):573-8. PubMed ID: 11239500
    [Abstract] [Full Text] [Related]

  • 13. Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell lines.
    Shellard SA, Fichtinger-Schepman AM, Lazo JS, Hill BT.
    Anticancer Drugs; 1993 Aug 01; 4(4):491-500. PubMed ID: 8400352
    [Abstract] [Full Text] [Related]

  • 14. Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells.
    Blommaert FA, van Dijk-Knijnenburg HC, Dijt FJ, den Engelse L, Baan RA, Berends F, Fichtinger-Schepman AM.
    Biochemistry; 1995 Jul 04; 34(26):8474-80. PubMed ID: 7599137
    [Abstract] [Full Text] [Related]

  • 15. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
    Shellard SA, Hosking LK, Hill BT.
    Cancer Res; 1991 Sep 01; 51(17):4557-64. PubMed ID: 1873800
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.
    Hettinga JV, Lemstra W, Meijer C, Dam WA, Uges DR, Konings AW, De Vries EG, Kampinga HH.
    Br J Cancer; 1997 Sep 01; 75(12):1735-43. PubMed ID: 9192975
    [Abstract] [Full Text] [Related]

  • 17. Correlation of the response to cisplatin of human ovarian cancer cell lines, originating from one tumor but with different sensitivity, with the recovery of DNA adducts.
    De Pooter CM, Van Oosterom AT, Scalliet PG, Maes RA, de Bruijn EA.
    Biochem Pharmacol; 1996 Mar 08; 51(5):629-34. PubMed ID: 8615899
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.
    van Moorsel CJ, Pinedo HM, Veerman G, Bergman AM, Kuiper CM, Vermorken JB, van der Vijgh WJ, Peters GJ.
    Br J Cancer; 1999 Jun 08; 80(7):981-90. PubMed ID: 10362105
    [Abstract] [Full Text] [Related]

  • 19. Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients.
    Hill BT, Scanlon KJ, Hansson J, Harstrick A, Pera M, Fichtinger-Schepman AM, Shellard SA.
    Eur J Cancer; 1994 Jun 08; 30A(6):832-7. PubMed ID: 7917544
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC, Shellard SA, Hosking LK, Fichtinger-Schepman AM, Hill BT.
    Carcinogenesis; 1992 Jul 08; 13(7):1209-15. PubMed ID: 1638688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.